- ReviewMasanori Kawakami, Lisa Maria Mustachio, Xi Liu and Ethan DmitrovskyMol Cancer Ther April 1 2018 17 (4) 724-731; DOI:10.1158/1535-7163.MCT-17-1108
- Small Molecule Therapeutics | AuthorChoiceSean P. Pitroda, Melinda E. Stack, Gene-Fu Liu, Sui-Sui Song, Lucy Chen, Hua Liang, Akash D. Parekh, Xiaona Huang, Paul Roach, Mitchell C. Posner, Ralph R. Weichselbaum and Nikolai N. KhodarevMol Cancer Ther April 1 2018 17 (4) 732-739; DOI:10.1158/1535-7163.MCT-17-0667
- Large Molecule TherapeuticsDanielle Mandikian, Nene Takahashi, Amy A. Lo, Ji Li, Jeffrey Eastham-Anderson, Dionysos Slaga, Jason Ho, Maria Hristopoulos, Robyn Clark, Klara Totpal, Kedan Lin, Sean B. Joseph, Mark S. Dennis, Saileta Prabhu, Teemu T. Junttila and C. Andrew BoswellMol Cancer Ther April 1 2018 17 (4) 776-785; DOI:10.1158/1535-7163.MCT-17-0657
- Cancer Biology and Translational StudiesGuangming Chen, Chenxi Gao, Xuan Gao, Dennis Han Zhang, Shih-Fan Kuan, Timothy F. Burns and Jing HuMol Cancer Ther April 1 2018 17 (4) 806-813; DOI:10.1158/1535-7163.MCT-17-0561
- Companion Diagnostic, Pharmacogenomic, and Cancer BiomarkersHee Kyung Kim, InKyoung Lee, Heejin Bang, Hee Cheol Kim, Woo Yong Lee, Seong Hyeon Yun, Jeeyun Lee, Su Jin Lee, Young Suk Park, Kyoung-Mee Kim and Won Ki KangMol Cancer Ther April 1 2018 17 (4) 838-848; DOI:10.1158/1535-7163.MCT-17-0535
- Models and TechnologiesJeremy M. Brownstein, Amy J. Wisdom, Katherine D. Castle, Yvonne M. Mowery, Peter Guida, Chang-Lung Lee, Francesco Tommasino, Chiara La Tessa, Emanuele Scifoni, Junheng Gao, Lixia Luo, Lorraine Da Silva Campos, Yan Ma, Nerissa Williams, Sin-Ho Jung, Marco Durante and David G. KirschMol Cancer Ther April 1 2018 17 (4) 858-868; DOI:10.1158/1535-7163.MCT-17-0965
- ReviewBayley A. Jones, Sooryanarayana Varambally and Rebecca C. ArendMol Cancer Ther March 1 2018 17 (3) 591-602; DOI:10.1158/1535-7163.MCT-17-0437
- ReviewYoung Kwang Chae, Alan P. Pan, Andrew A. Davis, Sandip P. Patel, Benedito A. Carneiro, Razelle Kurzrock and Francis J. GilesMol Cancer Ther December 1 2017 16 (12) 2645-2655; DOI:10.1158/1535-7163.MCT-17-0597
- ReviewLing Ni and Chen DongMol Cancer Ther July 1 2017 16 (7) 1203-1211; DOI:10.1158/1535-7163.MCT-16-0761
OnlineFirst Articles
- Induction of telomere damage to treat pediatric brain tumorsSatarupa Sengupta, et al.
- Hypersensitivity of BRCA1/2-deficient cells to APTO-253Cheng-Yu Tsai, et al.
- A synthetic BRCA2 peptide inhibits RAD51Anika Trenner, et al.
- MAPK reactivation facilitates resistance to FGFR inhibitionBruno Bockorny, et al.
Advertisement